BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

Andere Sprachen Biohaven Pharmaceutical Holding Company Ltd.

Aktien

A2DQ7W

VGG111961055

BHVN

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 25.04.2024			% 5 Tage	% 1. Jan.
38,54 ^USD	-0,46 %		-8,59 %	-74,61 %

25.04.	Biohaven-Insider kaufte Aktien im Wert von $999.169, laut einer aktuellen SEC-Anmeldung	MT
23.04.	Biohaven-Aktien steigen nach Abschluss des öffentlichen Angebots und Offenlegung des Aktienkaufs durch den CEO	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing	25.04.
Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO	23.04.
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares	23.04.
Biohaven Insider Bought Shares Worth $7,999,961, According to a Recent SEC Filing	23.04.
Biohaven Insider Bought Shares Worth $4,999,991, According to a Recent SEC Filing	23.04.
Biohaven Announces Pricing of $230 Million Public Offering of Common Shares	19.04.
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	18.04.
Biohaven Prices $230 Million Public Share Offering	18.04.
Biohaven Launches $200 Million Common Stock Offering	17.04.
Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology Annual Meeting and Provides Other Business Updates	15.04.
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments	01.03.
Biohaven Q4 Non-GAAP Net Loss Widens, Shares Fall After-Hours	29.02.
Biohaven Highlights Progress across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference	09.01.
Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03.01.
Biohaven Insider Sold Shares Worth $459,663, According to a Recent SEC Filing	02.01.
Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting	04.12.
Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments	15.11.
Biohaven Pharmaceutical Q3 Net Loss Narrows	14.11.
Biohaven Presents Preclinical Data Demonstrating Taldefgrobep alfa Reduces Fat and Improves Lean Mass at The Obesity Society's Annual Meeting, ObesityWeek	17.10.23
Biohaven Pharmaceutical Says Obesity Treatment Candidate Reduces Fat, Improves Lean Mass	16.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Biohaven Pharmaceutical Holding Company Ltd.

Aktien

A2DQ7W

VGG111961055

BHVN

Andere Sprachen

Filter